Coryfin
Italy
Table of Contents
Package leaflet: Information for the user
Coryfin 2.8 mg + 16.8 mg tablets
menthol ethyl glycolate + sodium ascorbate
Please read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you to.
- Keep this leaflet. You may need to read it again.
- If you need more advice or information, consult your pharmacist.
- If you experience any side effects, including those not listed in this leaflet, consult your doctor or pharmacist. See section 4.
- Consult your doctor if you do not notice improvement or if your symptoms worsen after three days.
Contents of this leaflet:
- What Coryfin is and what it is used for
- What you need to know before taking Coryfin
- How to take Coryfin
- Possible side effects
- How to store Coryfin
- Contents of the pack and other information
1. What Coryfin is and what it is used for
Coryfin is used in the treatment of cough and voice disturbances (hoarseness) as it relieves throat irritation and reduces phlegm, including in smokers.
Consult your doctor if you do not feel better or if you feel worse after three days.
2. What you need to know before using Coryfin
Do not use Coryfin
- if you are allergic to the active substances or to any of the other ingredients of this medicine (listed in section 6);
- in children under 30 months of age;
- in children who suffer from epilepsy;
- in children who have had seizures (violent and involuntary muscle contractions) related to fever (febrile seizures).
Warnings and precautions
Talk to your doctor or pharmacist before using Coryfin.
This product contains menthol, a balsamic substance (terpene derivative) which, in large quantities,
may cause seizures in newborns and children.
Do not use this medicine for more than 3 days, to avoid accumulation in your body and brain of certain substances contained in
this medicine, namely terpene derivatives.
Do not exceed the recommended dose (see section 3 “If you use more Coryfin than you should” and
section 4 “Side effects”).
The product is flammable; keep away from flames.
Other medicines and Coryfin
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Coryfin must not be used together with other products (medicinal or cosmetic) containing
terpene derivatives (for example: camphor, cineole, niaouli, wild thyme, terpineol, terpin, citral,
menthol, and essential oils of pine needles, eucalyptus, and turpentine).
Coryfin with food, drinks and alcohol
No interactions are known.
Pregnancy and breastfeeding
If you are pregnant, think you might be pregnant, are planning a pregnancy, or are breastfeeding, please consult your doctor or pharmacist before using this medicine.
This medicine is not recommended during pregnancy and in women of childbearing potential who do not use contraception methods to prevent pregnancy.
This medicine must not be used during breastfeeding.
Driving and using machines
This medicine does not impair the ability to drive or operate machinery.
Coryfin contains glucose and sucrose. If your doctor has diagnosed you with an intolerance to certain sugars, contact him/her before taking this medicine.
This medicine contains 0.9 g of sucrose per tablet and 1.1 g of glucose per tablet.
This should be taken into consideration in patients with diabetes mellitus.
3. How to use Coryfin
Use this medicine exactly as stated in this leaflet or as directed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Do not exceed the recommended doses.
The recommended dose is one tablet every 1–2 hours, up to a maximum of 8 tablets per day.
Use in children
This medicine must not be used in children below 30 months of age.
In children above 30 months of age, the dose should be halved (up to a maximum of 4 tablets per day).
Duration of treatment: Treatment duration must not exceed 3 days.
If you take more Coryfin than you should
In case of accidental ingestion of this medicine by newborns or ingestion of higher than recommended doses in children, there may be a risk of seizures (violent, involuntary muscle contractions) due to the presence of menthol. In such cases, go immediately to the nearest emergency room or contact a doctor.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody will experience them.
In rare cases, sensitization reactions (excessive reaction of the body to foreign substances it has come into contact with, which may lead to allergy) or irritation may occur.
If this happens, stop treatment and consult a doctor.
Additional side effects in children
If doses higher than those indicated are taken, children may experience severe and involuntary muscle contractions (convulsions) due to the presence of menthol (see also section 3, “If you use more Coryfin than you should”).
Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the website: http://www.agenziafarmaco.gov.it/it/responsabili .
By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Coryfin
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "Exp.". The expiry date refers to the last day of that month.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What Coryfin contains
In one Coryfin tablet:
- The active substances are: ethylglycolate menthol 2.8 mg, sodium ascorbate 16.8 mg (equivalent to 15 mg of ascorbic acid or Vitamin C).
- The other components are: menthol, citric acid, lemon flavour, sucrose, glucose.
Description of the appearance of Coryfin and pack contents
Coryfin is presented in a box containing 24 tablets in blister packs.
Marketing Authorisation Holder and Manufacturer
Laboratorio Farmaceutico SIT S.r.l. - Via Cavour, 70 – 27035 Mede (PV)
Package leaflet: Information for the user
Coryfin 6.5 mg + 18 mg tablets
menthol ethyl glycolate + sodium ascorbate
Please read this leaflet carefully before using this medicine because it contains
important information for you.
Always use this medicine exactly as described in this leaflet or as your doctor or
pharmacist has instructed.
- Keep this leaflet. You may need to read it again.
- If you need more information or advice, consult your pharmacist.
- If you experience any side effects, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.
- Contact your doctor if you do not notice any improvement or if your symptoms worsen after three days.
Contents of this leaflet:
- What Coryfin is and what it is used for
- What you need to know before using Coryfin
- How to use Coryfin
- Possible side effects
- How to store Coryfin
- Package contents and other information
1. What Coryfin is and what it is used for
Coryfin is used in the treatment of cough and voice alterations (hoarseness) because it relieves throat irritation and reduces phlegm, including in smokers.
Consult your doctor if you do not feel better or if you feel worse after three days.
2. What you should know before using Coryfin
Do not use Coryfin
- if you are allergic to the active substances or to any of the other ingredients of this medicine (listed in section 6);
- in children under 30 months of age;
- in children suffering from epilepsy;
- in children who have experienced seizures (violent, involuntary muscle contractions) related to fever (febrile seizures).
Warnings and precautions
Talk to your doctor or pharmacist before using Coryfin.
This product contains menthol, a balsamic substance (terpene derivative) which, in large quantities,
may cause seizures in newborns and children.
Do not use this medicine for more than 3 days, to avoid accumulation in your body and brain of certain substances contained in
this medicine, namely terpene derivatives.
Do not exceed the recommended dose (see section 3 “If you use more Coryfin than you should” and
section 4 “Side effects”).
The product is flammable; keep away from open flames.
Other medicines and Coryfin
Inform your doctor or pharmacist if you are taking, have recently taken, or might take
any other medicines.
Coryfin must not be used together with other products (medicines or cosmetics) containing terpene derivatives (for example: camphor, cineole, niaouli, wild thyme, terpineol, terpin, citral, menthol, and essential oils of pine needles, eucalyptus, and turpentine).
Coryfin with food, drinks and alcohol
No interactions are known.
Pregnancy and breastfeeding
If you are pregnant, think you might be pregnant, planning a pregnancy, or breastfeeding, consult your doctor or pharmacist before using this medicine.
This medicine is not recommended during pregnancy and in women of childbearing age who are not using contraception.
This medicine must not be used during breastfeeding.
Driving and using machines
This medicine does not impair the ability to drive or operate machinery.
Coryfin contains glucose and sucrose. If your doctor has diagnosed you with an intolerance to certain
sugars, contact him before taking this medicine.
This medicine contains 0.9 g of sucrose per tablet and 1.1 g of glucose per tablet.
This should be taken into account in patients with diabetes mellitus.
3. How to use Coryfin
Use this medicine exactly as stated in this leaflet or as directed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Do not exceed the recommended doses.
The recommended dose is one tablet every 1–2 hours, up to a maximum of 8 tablets per day.
Use in children
This medicine must not be used in children under 30 months of age.
In children above 30 months of age, the dose should be halved (up to a maximum of 4 tablets per day).
Duration of treatment: Treatment duration must not exceed 3 days.
If you take more Coryfin than you should
In case of accidental ingestion of this medicine by newborns, or if doses higher than recommended are taken by children, there may be a risk of seizures (violent, involuntary muscle contractions) due to the presence of menthol. In such cases, go immediately to the nearest emergency room or contact a doctor.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
In rare cases, sensitization reactions (excessive reaction of the body to foreign substances it has come into contact with, which may lead to allergy) or irritation may occur.
If this happens, discontinue treatment and consult a doctor.
Additional side effects in children
If doses higher than those indicated are taken, severe and involuntary muscle contractions (convulsions) may occur in children due to the presence of menthol (see also section 3 “If you take more Coryfin than you should”).
Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the website:
http://www.agenziafarmaco.gov.it/it/responsabili .
By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Coryfin
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pack after “Exp.”. The expiry date refers to the last day of that month.
Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.
6. Package contents and other information
What Coryfin contains
In one Coryfin tablet:
- The active substances are: ethylglycolate menthol 6.5 mg, sodium ascorbate 18 mg (equivalent to 16 mg of ascorbic acid or Vitamin C).
- The other components are: eucalyptol-menthol flavour, citric acid, sucrose, glucose.
Description of the appearance of Coryfin and package contents
Coryfin is available in a box containing 24 tablets in blister packs.
Marketing Authorization Holder and Manufacturer
Laboratorio Farmaceutico SIT S.r.l. - Via Cavour, 70 – 27035 Mede (PV)
Package leaflet: Information for the user
Coryfin 6.5 mg + 112.5 mg tablets
menthol ethyl glycolate + sodium ascorbate
Please read this leaflet carefully before using this medicine because it contains
important information for you.
Use this medicine exactly as described in this leaflet or as your doctor or
pharmacist has instructed you.
- Keep this leaflet. You may need to read it again.
- If you need more information or advice, consult your pharmacist.
- If you experience any side effects, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.
- Contact your doctor if you do not notice any improvement or if your symptoms worsen after three days.
Contents of this leaflet:
- What Coryfin is and what it is used for
- What you need to know before using Coryfin
- How to use Coryfin
- Possible side effects
- How to store Coryfin
- Package contents and other information
1. What Coryfin is and what it is used for
Coryfin is used in the treatment of cough and voice alterations (hoarseness) because it relieves throat irritation and reduces phlegm, including in smokers.
Consult your doctor if you do not feel better or if you feel worse after three days.
2. What you need to know before using Coryfin
Do not use Coryfin
- if you are allergic to the active substances or to any of the other ingredients of this medicine (listed in section 6);
- in children under 30 months of age;
- in children suffering from epilepsy;
- in children who have had seizures (violent, involuntary muscle contractions) related to fever (febrile seizures).
Warnings and precautions
Talk to your doctor or pharmacist before using Coryfin.
This product contains menthol, a balsamic substance (terpene derivative) which, in large quantities,
may cause seizures in newborns and children.
Do not use this medicine for more than 3 days, to avoid accumulation in your body and brain of certain substances contained in
this medicine, namely terpene derivatives.
Do not exceed the recommended dose (see section 3 “If you use more Coryfin than you should” and
section 4 “Side effects”).
The product is flammable; keep away from open flames.
Other medicines and Coryfin
Inform your doctor or pharmacist if you are taking, have recently taken, or might take
any other medicines.
Coryfin must not be used together with other products (medicinal or cosmetic) containing terpene
derivatives (for example: camphor, cineole, niaouli, wild thyme, terpineol, terpina, citral, menthol,
and essential oils of pine needles, eucalyptus, and turpentine).
Coryfin with food, drinks and alcohol
No interactions are known.
Pregnancy and breastfeeding
If you are pregnant, think you might be pregnant, are planning a pregnancy, or are breastfeeding,
ask your doctor or pharmacist for advice before using this medicine.
This medicine is not recommended during pregnancy and in women of childbearing age who do not use
contraceptive methods to prevent pregnancy.
This medicine must not be used during breastfeeding.
Driving and using machines
This medicine does not affect the ability to drive or operate machinery.
Coryfin contains glucose and sucrose. If your doctor has diagnosed you with an intolerance to certain
sugars, contact him or her before taking this medicine.
This medicine contains 0.8 g of sucrose per tablet and 1 g of glucose per tablet.
This should be taken into consideration in patients with diabetes mellitus.
3. How to use Coryfin
Use this medicine exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Do not exceed the recommended doses.
The recommended dose is one tablet every 2–3 hours, up to a maximum of 6 tablets per day.
Use in children
This medicine must not be used in children under 30 months of age.
In children over 30 months of age, the dose should be halved (up to a maximum of 3 tablets per day).
Duration of treatment: Treatment duration must not exceed 3 days.
If you use more Coryfin than you should
If this medicine is accidentally ingested by newborns or if children take higher than recommended doses, there may be a risk of seizures (violent, involuntary muscle contractions) due to the presence of menthol. In such cases, go immediately to the nearest emergency room or contact a doctor.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody will get them.
In rare cases, sensitization reactions (excessive reaction of the body to foreign substances it has come into contact with, which may lead to allergy) or irritation may occur.
If this happens, stop treatment and consult a doctor.
Additional side effects in children
If doses higher than those indicated are taken, severe and involuntary muscle contractions (convulsions) may occur in children due to the presence of menthol (see also section 3 “If you use more Coryfin than you should”).
Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the website:
http://www.agenziafarmaco.gov.it/it/responsabili .
By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Coryfin
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after "Exp.". The expiry date refers to the last day of that month.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.
6. Package contents and other information
What Coryfin contains
In one Coryfin tablet:
- The active substances are: ethylglycolate menthol 6.5 mg, sodium ascorbate 112.5 mg (equivalent to 100 mg of ascorbic acid or Vitamin C).
- The other components are: menthol, tangerine flavour, citric acid, sucrose, glucose.
Description of the appearance of Coryfin and package contents
Coryfin is presented in a box containing 24 tablets in blisters.
Marketing Authorization Holder and Manufacturer
Laboratorio Farmaceutico SIT S.r.l. - Via Cavour, 70 – 27035 Mede (PV)